Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01876238 · ClinicalTrials.gov registry record · NA

Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals in Breast Cancer

A NA study of Advanced Breast Cancer and Recurrent Breast Cancer, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT01876238: Completed NA study of Advanced Breast Cancer and Recurrent Breast Cancer, sponsored by Case Comprehensive Cancer Center.

NCT01876238 is a NA study of Advanced Breast Cancer and Recurrent Breast Cancer that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 29 participants, below the 464-participant average among 28 other Advanced Breast Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01876238, a NA study of Advanced Breast Cancer and Recurrent Breast Cancer, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

This research study will examine how patients with advanced breast cancer and their oncology team communicate and plan ongoing care.The purpose of this study is to find out more about care planning during advanced breast cancer. The study will see if certain aspects of communication make a difference in how patients understand their illness.

Primary Outcome

Accuracy and completion rate of the planned intervention components will be observed.

Interventions

  • OTHER Surveys
  • OTHER T-PAT

Study Locations (1)

Ohio

  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center - Cleveland

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2013-05
Est. Completion 2015-06
Phase NA
Case Comprehensive Cancer Center

407 total trials

What the finished NCT01876238 record still lists

NCT01876238 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 464-participant average among 28 other Advanced Breast Cancer trials with a reported enrollment target (94% lower).

The record links to 3 conditions, with Advanced Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Surveys is the first listed.

NCT01876238 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01876238 about?

NCT01876238 is a clinical study titled "Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals in Breast Cancer". This research study will examine how patients with advanced breast cancer and their oncology team communicate and plan ongoing care.The purpose of this study is to find out more about care planning during advanced breast cancer. The study will see if certain aspects of communication make a differenc...

What is the current status of trial NCT01876238?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2013-05. Estimated completion is 2015-06.

What conditions does trial NCT01876238 study?

This clinical trial studies the following conditions: Advanced Breast Cancer, Recurrent Breast Cancer, Stage 4 Breast Cancer.

What interventions are being tested in trial NCT01876238?

The interventions under investigation include: Surveys (OTHER), T-PAT (OTHER).

Who is sponsoring clinical trial NCT01876238?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01876238 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Advanced Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01876238's enrollment target sits among peer trials

29 27th of 28 higher than 2 of 28 other Advanced Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Advanced Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01876238, the US trial registry maintained by the National Library of Medicine. NCT01876238 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.